Catabasis Pharmaceuticals, Inc. To Present At International Ataxia Research Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that CAT-4001 will be featured in a poster presentation at the upcoming International Ataxia Research Conference. The International Ataxia Research Conference will be held March 25-28, 2015, in Windsor, UK, at the Beaumont Estate.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC